Error: Could not add to watchlist. X

Halozyme Therapeutics Inc

+ Watchlist
HALO:US
NASDAQ GS
22.10
USD
0.40
1.78%
As of 17:20:00 ET on 07/02/2015.
Open
22.44
Day Range
21.63 - 22.47
Volume
992,983
Previous Close
22.50
52Wk Range
7.51 - 23.16
1 Yr Return
119.46%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.45
Market Cap (b USD)
2.812
Shares Outstanding (m)
127.260
Price/Sales (TTM)
33.50
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
ADDRESS
11388 Sorrento Valley Road
San Diego, CA 92121
United States
PHONE
1-858-794-8889
  • Helen I Torley
    President/CEO
  • Laurie Stelzer
    Senior VP/CFO
  • Athena Countouriotis
    Chief Medical Officer
  • Harry J Leonhardt
    Senior VP/Chief Compliance Ofcr
  • H Michael Shepard "Mike"
    VP/Chief Scientific Officer
Show More